Skip to main content
. 2020 Jul 6;8(13):2738–2748. doi: 10.12998/wjcc.v8.i13.2738

Table 3.

Comparison of incidence of adverse reactions, n (%)

Control group (n = 53) Experimental group (n = 61) χ2 P vulue
Hypotension 2 (3.77) 2 (3.28) - -
Arrhythmia 2 (3.77) 1 (1.64) - -
Hypertension 3 (5.66) 3 (4.92) - -
Vomiting 2 (3.77) 3 (4.92) - -
Headache 2 (3.77) 1 (1.64) - -
Total incidence of adverse reactions 11 (20.75) 10 (16.39) 0.829 0.363